| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.87 | 0.001 | 0.984 | ABCA1 expression enhancer | 0.984 0 DB11091 | DB11091 | |
| 0.52 | 0.005 | 0.664 | Alpha-N-acetylglucosaminidase inhibitor | 0.652 0.003 DBMET02108 0.664 0.003 DB11091 0.652 0.003 DB09460 | DB11091 | |
| 0.527 | 0.019 | 0.614 | GABA C receptor rho-3 antagonist | 0.614 0.006 DBMET02108 0.607 0.007 DB11091 0.614 0.006 DB09460 | DB09460 | |
| 0.428 | 0.004 | 0.803 | Neurotrophic factor | 0.803 0.002 DB11091 | DB11091 | |
| 0.409 | 0.005 | 0.54 | GABA C receptor agonist | 0.526 0.003 DBMET02108 0.54 0.003 DB11091 0.526 0.003 DB09460 | DB11091 | |
| 0.456 | 0.057 | 0.536 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.536 0.02 DBMET02108 0.524 0.024 DB11091 0.536 0.02 DB09460 | DB09460 | |
| 0.378 | 0.024 | 0.505 | Peroxidase inhibitor | 0.481 0.011 DBMET02108 0.505 0.009 DB11091 0.481 0.011 DB09460 | DB11091 | |
| 0.391 | 0.048 | 0.596 | Aldehyde oxidase inhibitor | 0.57 0.023 DBMET02108 0.596 0.019 DB11091 0.57 0.023 DB09460 | DB11091 | |
| 0.383 | 0.049 | 0.558 | 5 Hydroxytryptamine release stimulant | 0.537 0.022 DBMET02108 0.558 0.019 DB11091 0.537 0.022 DB09460 | DB11091 | |
| 0.349 | 0.024 | 0.446 | RNA-directed DNA polymerase inhibitor | 0.421 0.016 DBMET02108 0.446 0.014 DB11091 0.421 0.016 DB09460 | DB11091 | |
| 0.329 | 0.022 | 0.402 | Tyrosine 3 hydroxylase inhibitor | 0.394 0.009 DBMET02108 0.402 0.008 DB11091 0.394 0.009 DB09460 | DB11091 | |
| 0.336 | 0.03 | 0.427 | 5 Hydroxytryptamine uptake stimulant | 0.427 0.01 DBMET02108 0.427 0.01 DB11091 0.427 0.01 DB09460 | DB09460 | |
| 0.389 | 0.085 | 0.496 | 5 Hydroxytryptamine release inhibitor | 0.496 0.034 DBMET02108 0.496 0.034 DB11091 0.496 0.034 DB09460 | DB09460 | |
| 0.31 | 0.007 | 0.398 | Ferrochelatase inhibitor | 0.398 0.004 DBMET02108 0.397 0.004 DB11091 0.398 0.004 DB09460 | DB09460 | |
| 0.261 | 0.019 | 0.433 | Succinate dehydrogenase inhibitor | 0.433 0.004 DBMET02108 0.323 0.008 DB11091 0.433 0.004 DB09460 | DB09460 | |
| 0.235 | 0.014 | 0.432 | UDP-glucose 4-epimerase inhibitor | 0.432 0.004 DBMET02108 0.34 0.008 DB11091 0.432 0.004 DB09460 | DB09460 | |
| 0.244 | 0.037 | 0.294 | Nitric-oxide synthase stimulant | 0.294 0.013 DBMET02108 0.292 0.013 DB11091 0.294 0.013 DB09460 | DB09460 | |
| 0.231 | 0.027 | 0.274 | 5 Hydroxytryptamine 3E antagonist | 0.274 0.008 DBMET02108 0.268 0.01 DB11091 0.274 0.008 DB09460 | DB09460 | |
| 0.297 | 0.095 | 0.38 | Calcium channel activator | 0.38 0.033 DBMET02108 0.376 0.035 DB11091 0.38 0.033 DB09460 | DB09460 | |
| 0.208 | 0.01 | 0.305 | Triose-phosphate isomerase inhibitor | 0.296 0.005 DBMET02108 0.305 0.005 DB11091 0.296 0.005 DB09460 | DB11091 | |
| 0.208 | 0.014 | 0.284 | Adenylate kinase inhibitor | 0.277 0.008 DBMET02108 0.284 0.008 DB11091 0.277 0.008 DB09460 | DB11091 | |
| 0.256 | 0.071 | 0.387 | Superoxide dismutase inhibitor | 0.378 0.031 DBMET02108 0.387 0.029 DB11091 0.378 0.031 DB09460 | DB11091 | |
| 0.339 | 0.155 | 0.471 | Caspase 9 stimulant | 0.468 0.074 DBMET02108 0.471 0.072 DB11091 0.468 0.074 DB09460 | DB11091 | |
| 0.208 | 0.025 | 0.273 | GABA C receptor rho-2 antagonist | 0.273 0.008 DBMET02108 0.267 0.009 DB11091 0.273 0.008 DB09460 | DB09460 | |
| 0.196 | 0.014 | 0.279 | GABA C receptor antagonist | 0.257 0.006 DBMET02108 0.279 0.005 DB11091 0.257 0.006 DB09460 | DB11091 | |
| 0.188 | 0.011 | 0.269 | NADH dehydrogenase inhibitor | 0.251 0.008 DBMET02108 0.269 0.007 DB11091 0.251 0.008 DB09460 | DB11091 | |
| 0.188 | 0.014 | 0.297 | Porphobilinogen synthase inhibitor | 0.287 0.005 DBMET02108 0.297 0.005 DB11091 0.287 0.005 DB09460 | DB11091 | |
| 0.175 | 0.003 | 0.419 | AMPA receptor agonist | 0.419 0.001 DB11091 | DB11091 | |
| 0.19 | 0.017 | 0.279 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.273 0.008 DBMET02108 0.279 0.007 DB11091 0.273 0.008 DB09460 | DB11091 | |
| 0.179 | 0.008 | 0.194 | Ca2+-transporting ATPase inhibitor | 0.192 0.004 DBMET02108 0.194 0.004 DB11091 0.192 0.004 DB09460 | DB11091 | |
| 0.176 | 0.008 | 0.81 | Alcohol oxidase inhibitor | 0.81 0.003 DBMET02108 0.385 0.004 DB11091 0.81 0.003 DB09460 | DB09460 | |
| 0.2 | 0.033 | 0.243 | Arachidonic acid antagonist | 0.243 0.007 DBMET02108 0.221 0.016 DB11091 0.243 0.007 DB09460 | DB09460 | |
| 0.172 | 0.014 | 0.234 | GABA C receptor rho-1 antagonist | 0.223 0.005 DBMET02108 0.234 0.005 DB11091 0.223 0.005 DB09460 | DB11091 | |
| 0.17 | 0.015 | 0.225 | Phosphofructokinase-1 inhibitor | 0.218 0.009 DBMET02108 0.225 0.009 DB11091 0.218 0.009 DB09460 | DB11091 | |
| 0.169 | 0.017 | 0.23 | Creatine kinase inhibitor | 0.214 0.009 DBMET02108 0.23 0.007 DB11091 0.214 0.009 DB09460 | DB11091 | |
| 0.161 | 0.01 | 0.22 | Carbamoyl phosphate synthetase inhibitor | 0.212 0.007 DBMET02108 0.22 0.006 DB11091 0.212 0.007 DB09460 | DB11091 | |
| 0.146 | 0.01 | 0.212 | Biliverdin reductase inhibitor | 0.208 0.005 DBMET02108 0.212 0.005 DB11091 0.208 0.005 DB09460 | DB11091 | |
| 0.17 | 0.035 | 0.2 | Adenylate cyclase stimulant | 0.195 0.016 DBMET02108 0.2 0.014 DB11091 0.195 0.016 DB09460 | DB11091 | |
| 0.142 | 0.01 | 0.241 | Acyl-CoA dehydrogenase inhibitor | 0.241 0.003 DBMET02108 0.194 0.005 DB11091 0.241 0.003 DB09460 | DB09460 | |
| 0.223 | 0.091 | 0.297 | DNA synthesis inhibitor | 0.287 0.048 DBMET02108 0.297 0.045 DB11091 0.287 0.048 DB09460 | DB11091 | |
| 0.163 | 0.035 | 0.234 | Cystathionine beta-synthase inhibitor | 0.226 0.019 DBMET02108 0.234 0.018 DB11091 0.226 0.019 DB09460 | DB11091 | |
| 0.147 | 0.023 | 0.182 | DOPA decarboxylase inhibitor | 0.177 0.011 DBMET02108 0.182 0.01 DB11091 0.177 0.011 DB09460 | DB11091 | |
| 0.137 | 0.018 | 0.196 | Glutamate dehydrogenase inhibitor | 0.19 0.011 DBMET02108 0.196 0.01 DB11091 0.19 0.011 DB09460 | DB11091 | |
| 0.192 | 0.079 | 0.275 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.269 0.034 DBMET02108 0.275 0.032 DB11091 0.269 0.034 DB09460 | DB11091 | |
| 0.13 | 0.018 | 0.182 | Glutamate decarboxylase inhibitor | 0.178 0.009 DBMET02108 0.182 0.008 DB11091 0.178 0.009 DB09460 | DB11091 | |
| 0.228 | 0.12 | 0.299 | Insulysin inhibitor | 0.297 0.06 DBMET02108 0.299 0.059 DB11091 0.297 0.06 DB09460 | DB11091 | |
| 0.257 | 0.15 | 0.417 | Histamine release inhibitor | 0.411 0.07 DBMET02108 0.417 0.067 DB11091 0.411 0.07 DB09460 | DB11091 | |
| 0.146 | 0.039 | 0.185 | Aminopeptidase B inhibitor | 0.181 0.026 DBMET02108 0.185 0.025 DB11091 0.181 0.026 DB09460 | DB11091 | |
| 0.115 | 0.012 | 0.246 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.246 0.005 DBMET02108 0.168 0.008 DB11091 0.246 0.005 DB09460 | DB09460 | |
| 0.237 | 0.134 | 0.425 | Cholesterol antagonist | 0.425 0.045 DBMET02108 0.343 0.067 DB11091 0.425 0.045 DB09460 | DB09460 | |
| 0.108 | 0.007 | 0.159 | Aconitate hydratase inhibitor | 0.155 0.004 DBMET02108 0.159 0.004 DB11091 0.155 0.004 DB09460 | DB11091 | |
| 0.112 | 0.016 | 0.173 | Argininosuccinate synthase inhibitor | 0.171 0.01 DBMET02108 0.173 0.009 DB11091 0.171 0.01 DB09460 | DB11091 | |
| 0.128 | 0.033 | 0.149 | Anabolic | 0.147 0.019 DBMET02108 0.149 0.018 DB11091 0.147 0.019 DB09460 | DB11091 | |
| 0.125 | 0.033 | 0.178 | Electrolyte absorption antagonist | 0.174 0.012 DBMET02108 0.178 0.012 DB11091 0.174 0.012 DB09460 | DB11091 | |
| 0.112 | 0.021 | 0.141 | Granulocyte macrophage colony stimulating factor agonist | 0.141 0.007 DBMET02108 0.139 0.008 DB11091 0.141 0.007 DB09460 | DB09460 | |
| 0.096 | 0.005 | 0.12 | Glucose-6-phosphate isomerase inhibitor | 0.117 0.004 DBMET02108 0.12 0.004 DB11091 0.117 0.004 DB09460 | DB11091 | |
| 0.112 | 0.022 | 0.144 | Aminopeptidase I inhibitor | 0.14 0.014 DBMET02108 0.144 0.014 DB11091 0.14 0.014 DB09460 | DB11091 | |
| 0.151 | 0.063 | 0.303 | Mannose-6-phosphate isomerase inhibitor | 0.303 0.005 DBMET02108 0.215 0.023 DB11091 0.303 0.005 DB09460 | DB09460 | |
| 0.133 | 0.046 | 0.205 | 5 Hydroxytryptamine 3A agonist | 0.205 0.014 DBMET02108 0.196 0.016 DB11091 0.205 0.014 DB09460 | DB09460 | |
| 0.108 | 0.022 | 0.171 | Phenylalanine 4-hydroxylase inhibitor | 0.156 0.011 DBMET02108 0.171 0.009 DB11091 0.156 0.011 DB09460 | DB11091 | |
| 0.203 | 0.118 | 0.288 | Interleukin agonist | 0.288 0.054 DBMET02108 0.288 0.054 DB11091 0.288 0.054 DB09460 | DB09460 | |
| 0.179 | 0.099 | 0.27 | Neurotrophic factor enhancer | 0.27 0.029 DBMET02108 0.238 0.046 DB11091 0.27 0.029 DB09460 | DB09460 | |
| 0.119 | 0.039 | 0.169 | Prolactin inhibitor | 0.163 0.017 DBMET02108 0.169 0.015 DB11091 0.163 0.017 DB09460 | DB11091 | |
| 0.092 | 0.014 | 0.116 | Glutamate (mGluR6) antagonist | 0.114 0.007 DBMET02108 0.116 0.006 DB11091 0.114 0.007 DB09460 | DB11091 | |
| 0.151 | 0.076 | 0.192 | Interferon gamma antagonist | 0.186 0.047 DBMET02108 0.192 0.044 DB11091 0.186 0.047 DB09460 | DB11091 | |
| 0.104 | 0.03 | 0.2 | Histidine decarboxylase inhibitor | 0.189 0.014 DBMET02108 0.2 0.013 DB11091 0.189 0.014 DB09460 | DB11091 | |
| 0.098 | 0.027 | 0.117 | Estrogen-related receptor beta agonist | 0.114 0.013 DBMET02108 0.117 0.011 DB11091 0.114 0.013 DB09460 | DB11091 | |
| 0.13 | 0.059 | 0.21 | Alkylator | 0.19 0.029 DBMET02108 0.21 0.024 DB11091 0.19 0.029 DB09460 | DB11091 | |
| 0.115 | 0.045 | 0.89 | Hedgehog signaling inhibitor | 0.89 0.003 DB11091 | DB11091 | |
| 0.089 | 0.02 | 0.129 | Purinergic P2X1 antagonist | 0.123 0.011 DBMET02108 0.129 0.01 DB11091 0.123 0.011 DB09460 | DB11091 | |
| 0.148 | 0.08 | 0.191 | CF transmembrane conductance regulator agonist | 0.188 0.029 DBMET02108 0.191 0.027 DB11091 0.188 0.029 DB09460 | DB11091 | |
| 0.093 | 0.026 | 0.131 | Glycine receptor agonist | 0.128 0.011 DBMET02108 0.131 0.01 DB11091 0.128 0.011 DB09460 | DB11091 | |
| 0.09 | 0.023 | 0.108 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.106 0.01 DBMET02108 0.108 0.009 DB11091 0.106 0.01 DB09460 | DB11091 | |
| 0.206 | 0.14 | 0.276 | Gastrin inhibitor | 0.275 0.053 DBMET02108 0.276 0.052 DB11091 0.275 0.053 DB09460 | DB11091 | |
| 0.19 | 0.124 | 0.34 | DNA damaging | 0.287 0.063 DBMET02108 0.34 0.044 DB11091 0.287 0.063 DB09460 | DB11091 | |
| 0.097 | 0.033 | 0.118 | D-Ala-D-Ala ligase inhibitor | 0.115 0.016 DBMET02108 0.118 0.014 DB11091 0.115 0.016 DB09460 | DB11091 | |
| 0.157 | 0.093 | 0.201 | Phospholipase C inhibitor | 0.193 0.049 DBMET02108 0.201 0.043 DB11091 0.193 0.049 DB09460 | DB11091 | |
| 0.085 | 0.022 | 0.112 | Glutamate (mGluR7) antagonist | 0.112 0.006 DBMET02108 0.109 0.007 DB11091 0.112 0.006 DB09460 | DB09460 | |
| 0.096 | 0.036 | 0.129 | Glycine receptor antagonist | 0.128 0.014 DBMET02108 0.129 0.014 DB11091 0.128 0.014 DB09460 | DB11091 | |
| 0.08 | 0.021 | 0.115 | Ornithine carbamoyltransferase inhibitor | 0.11 0.014 DBMET02108 0.115 0.013 DB11091 0.11 0.014 DB09460 | DB11091 | |
| 0.1 | 0.042 | 0.137 | Glutamate release inhibitor | 0.137 0.014 DBMET02108 0.137 0.013 DB11091 0.137 0.014 DB09460 | DB09460 | |
| 0.087 | 0.029 | 0.109 | Vanilloid 4 agonist | 0.109 0.011 DBMET02108 0.108 0.012 DB11091 0.109 0.011 DB09460 | DB09460 | |
| 0.081 | 0.024 | 0.113 | Exportin-1 inhibitor | 0.113 0.005 DBMET02108 0.105 0.007 DB11091 0.113 0.005 DB09460 | DB09460 | |
| 0.106 | 0.05 | 0.168 | HIV-1 integrase (Overall Integration) inhibitor | 0.158 0.023 DBMET02108 0.168 0.019 DB11091 0.158 0.023 DB09460 | DB11091 | |
| 0.093 | 0.038 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 DBMET02108 0.108 0.025 DB11091 0.105 0.027 DB09460 | DB11091 | |
| 0.064 | 0.01 | 0.092 | Dopamine D5 agonist | 0.078 0.006 DBMET02108 0.092 0.005 DB11091 0.078 0.006 DB09460 | DB11091 | |
| 0.116 | 0.063 | 0.157 | Photosensitizer | 0.155 0.028 DBMET02108 0.157 0.027 DB11091 0.155 0.028 DB09460 | DB11091 | |
| 0.062 | 0.01 | 0.097 | Fumarate hydratase inhibitor | 0.094 0.006 DBMET02108 0.097 0.005 DB11091 0.094 0.006 DB09460 | DB11091 | |
| 0.069 | 0.018 | 0.089 | Alpha-mannosidase inhibitor | 0.083 0.01 DBMET02108 0.089 0.008 DB11091 0.083 0.01 DB09460 | DB11091 | |
| 0.123 | 0.072 | 0.168 | Cathepsin H inhibitor | 0.168 0.035 DBMET02108 0.165 0.037 DB11091 0.168 0.035 DB09460 | DB09460 | |
| 0.091 | 0.042 | 0.172 | Catalase inhibitor | 0.167 0.022 DBMET02108 0.172 0.021 DB11091 0.167 0.022 DB09460 | DB11091 | |
| 0.058 | 0.009 | 0.074 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 DBMET02108 0.074 0.004 DB11091 0.072 0.004 DB09460 | DB11091 | |
| 0.136 | 0.087 | 0.174 | Sphingosine 1-phosphate receptor 5 antagonist | 0.169 0.034 DBMET02108 0.174 0.029 DB11091 0.169 0.034 DB09460 | DB11091 | |
| 0.056 | 0.008 | 0.075 | Glutamate (mGluR8) agonist | 0.073 0.005 DBMET02108 0.075 0.004 DB11091 0.073 0.005 DB09460 | DB11091 | |
| 0.149 | 0.103 | 0.182 | Neurotensin receptor agonist | 0.179 0.05 DBMET02108 0.182 0.047 DB11091 0.179 0.05 DB09460 | DB11091 | |
| 0.08 | 0.034 | 0.108 | Phospholipase D inhibitor | 0.108 0.011 DBMET02108 0.106 0.011 DB11091 0.108 0.011 DB09460 | DB09460 | |
| 0.083 | 0.038 | 0.099 | MAP kinase kinase 7 inhibitor | 0.095 0.017 DBMET02108 0.099 0.014 DB11091 0.095 0.017 DB09460 | DB11091 | |
| 0.058 | 0.014 | 0.07 | Guanylate cyclase inhibitor | 0.068 0.005 DBMET02108 0.07 0.005 DB11091 0.068 0.005 DB09460 | DB11091 | |
| 0.054 | 0.01 | 0.069 | Kainate receptor agonist | 0.067 0.005 DBMET02108 0.069 0.005 DB11091 0.067 0.005 DB09460 | DB11091 | |
| 0.104 | 0.062 | 0.156 | Carbonic anhydrase XV inhibitor | 0.15 0.031 DBMET02108 0.156 0.029 DB11091 0.15 0.031 DB09460 | DB11091 | |
| 0.086 | 0.045 | 0.151 | Macrophage migration inhibitory factor inhibitor | 0.07 0.066 DBMET02108 0.151 0.015 DB11091 0.07 0.066 DB09460 | DB11091 | |
| 0.064 | 0.023 | 0.079 | Pregnane X receptor antagonist | 0.078 0.007 DBMET02108 0.079 0.007 DB11091 0.078 0.007 DB09460 | DB11091 | |
| 0.135 | 0.096 | 0.157 | Heat shock protein 70 antagonist | 0.157 0.033 DBMET02108 0.157 0.031 DB11091 0.157 0.033 DB09460 | DB09460 | |
| 0.08 | 0.042 | 0.148 | GABA B receptor agonist | 0.148 0.004 DBMET02108 0.104 0.014 DB11091 0.148 0.004 DB09460 | DB09460 | |
| 0.124 | 0.086 | 0.16 | Sphingosine 1-phosphate receptor 2 antagonist | 0.155 0.034 DBMET02108 0.16 0.03 DB11091 0.155 0.034 DB09460 | DB11091 | |
| 0.063 | 0.025 | 0.115 | Dihydroorotate oxidase inhibitor | 0.115 0.004 DBMET02108 0.082 0.009 DB11091 0.115 0.004 DB09460 | DB09460 | |
| 0.097 | 0.06 | 0.134 | Lanosterol 14 alpha demethylase inhibitor | 0.131 0.021 DBMET02108 0.134 0.019 DB11091 0.131 0.021 DB09460 | DB11091 | |
| 0.056 | 0.019 | 0.079 | Mannosidase inhibitor | 0.072 0.011 DBMET02108 0.079 0.009 DB11091 0.072 0.011 DB09460 | DB11091 | |
| 0.106 | 0.069 | 0.206 | Mucolytic | 0.206 0.012 DBMET02108 0.149 0.033 DB11091 0.206 0.012 DB09460 | DB09460 | |
| 0.15 | 0.114 | 0.422 | Anesthetic general | 0.422 0.014 DBMET02108 0.262 0.045 DB11091 0.422 0.014 DB09460 | DB09460 | |
| 0.137 | 0.102 | 0.169 | Melanin inhibitor | 0.164 0.065 DBMET02108 0.169 0.06 DB11091 0.164 0.065 DB09460 | DB11091 | |
| 0.055 | 0.021 | 0.088 | Adenylate cyclase 1 inhibitor | 0.088 0.005 DBMET02108 0.088 0.005 DB11091 0.088 0.005 DB09460 | DB09460 | |
| 0.109 | 0.076 | 0.215 | Microtubule formation inhibitor | 0.215 0.017 DBMET02108 0.149 0.038 DB11091 0.215 0.017 DB09460 | DB09460 | |
| 0.039 | 0.007 | 0.048 | Purinergic P2Y15 antagonist | 0.047 0.004 DBMET02108 0.048 0.004 DB11091 0.047 0.004 DB09460 | DB11091 | |
| 0.084 | 0.052 | 0.103 | CC chemokine 5 receptor agonist | 0.102 0.019 DBMET02108 0.103 0.019 DB11091 0.102 0.019 DB09460 | DB11091 | |
| 0.097 | 0.067 | 0.131 | Glutamate (mGluR7) agonist | 0.131 0.021 DBMET02108 0.126 0.025 DB11091 0.131 0.021 DB09460 | DB09460 | |
| 0.078 | 0.049 | 0.112 | GABA aminotransferase inhibitor | 0.11 0.021 DBMET02108 0.112 0.02 DB11091 0.11 0.021 DB09460 | DB11091 | |
| 0.048 | 0.018 | 0.076 | Alpha 1d adrenoreceptor agonist | 0.07 0.007 DBMET02108 0.076 0.006 DB11091 0.07 0.007 DB09460 | DB11091 | |
| 0.058 | 0.03 | 0.07 | Immunoglobulin Fc receptor antagonist | 0.069 0.012 DBMET02108 0.07 0.011 DB11091 0.069 0.012 DB09460 | DB11091 | |
| 0.039 | 0.013 | 0.073 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.073 0.005 DBMET02108 0.054 0.008 DB11091 0.073 0.005 DB09460 | DB09460 | |
| 0.078 | 0.052 | 0.112 | Keratolytic | 0.108 0.026 DBMET02108 0.112 0.024 DB11091 0.108 0.026 DB09460 | DB11091 | |
| 0.055 | 0.029 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | 0.069 0.015 DBMET02108 0.072 0.013 DB11091 0.069 0.015 DB09460 | DB11091 | |
| 0.084 | 0.059 | 0.11 | mTOR complex 2 inhibitor | 0.108 0.025 DBMET02108 0.11 0.024 DB11091 0.108 0.025 DB09460 | DB11091 | |
| 0.085 | 0.061 | 0.125 | Histamine N-methyltransferase inhibitor | 0.123 0.028 DBMET02108 0.125 0.026 DB11091 0.123 0.028 DB09460 | DB11091 | |
| 0.111 | 0.088 | 0.163 | Toll-Like receptor 2 antagonist | 0.158 0.047 DBMET02108 0.163 0.044 DB11091 0.158 0.047 DB09460 | DB11091 | |
| 0.048 | 0.025 | 0.082 | Geranyltranstransferase inhibitor | 0.082 0.005 DBMET02108 0.067 0.009 DB11091 0.082 0.005 DB09460 | DB09460 | |
| 0.104 | 0.082 | 0.148 | Cholesterol synthesis inhibitor | 0.14 0.05 DBMET02108 0.148 0.046 DB11091 0.14 0.05 DB09460 | DB11091 | |
| 0.031 | 0.009 | 0.039 | Vanilloid 2 agonist | 0.037 0.005 DBMET02108 0.039 0.004 DB11091 0.037 0.005 DB09460 | DB11091 | |
| 0.043 | 0.022 | 0.079 | Membrane dipeptidase inhibitor | 0.079 0.005 DBMET02108 0.057 0.012 DB11091 0.079 0.005 DB09460 | DB09460 | |
| 0.06 | 0.039 | 0.075 | Ryanodine receptor antagonist | 0.075 0.012 DBMET02108 0.075 0.012 DB11091 0.075 0.012 DB09460 | DB09460 | |
| 0.05 | 0.03 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.063 0.012 DBMET02108 0.067 0.01 DB11091 0.063 0.012 DB09460 | DB11091 | |
| 0.055 | 0.035 | 0.082 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.077 0.018 DBMET02108 0.082 0.015 DB11091 0.077 0.018 DB09460 | DB11091 | |
| 0.024 | 0.006 | 0.037 | Carbonic anhydrase X inhibitor | 0.037 0.004 DBMET02108 0.036 0.004 DB11091 0.037 0.004 DB09460 | DB09460 | |
| 0.024 | 0.006 | 0.037 | Carbonic anhydrase VIII inhibitor | 0.037 0.004 DBMET02108 0.036 0.004 DB11091 0.037 0.004 DB09460 | DB09460 | |
| 0.109 | 0.091 | 0.213 | Cyclooxygenase 3 inhibitor | 0.213 0.015 DBMET02108 0.156 0.043 DB11091 0.213 0.015 DB09460 | DB09460 | |
| 0.09 | 0.072 | 0.134 | Sphingomyelinase inhibitor | 0.127 0.036 DBMET02108 0.134 0.032 DB11091 0.127 0.036 DB09460 | DB11091 | |
| 0.045 | 0.027 | 0.058 | Histamine H1 receptor agonist | 0.058 0.01 DBMET02108 0.056 0.012 DB11091 0.058 0.01 DB09460 | DB09460 | |
| 0.034 | 0.018 | 0.057 | Glutamate (mGluR3) agonist | 0.057 0.004 DBMET02108 0.043 0.007 DB11091 0.057 0.004 DB09460 | DB09460 | |
| 0.044 | 0.028 | 0.064 | Oxytocin agonist | 0.064 0.014 DBMET02108 0.059 0.018 DB11091 0.064 0.014 DB09460 | DB09460 | |
| 0.022 | 0.006 | 0.027 | Telomerase stimulant | 0.025 0.004 DBMET02108 0.027 0.004 DB11091 0.025 0.004 DB09460 | DB11091 | |
| 0.029 | 0.014 | 0.037 | Hedgehog signaling activator | 0.036 0.006 DBMET02108 0.037 0.005 DB11091 0.036 0.006 DB09460 | DB11091 | |
| 0.043 | 0.029 | 0.06 | Nerve growth factor antagonist | 0.06 0.01 DBMET02108 0.059 0.01 DB11091 0.06 0.01 DB09460 | DB09460 | |
| 0.043 | 0.029 | 0.07 | Histamine H2 receptor agonist | 0.07 0.01 DBMET02108 0.064 0.013 DB11091 0.07 0.01 DB09460 | DB09460 | |
| 0.175 | 0.16 | 0.257 | 5 Hydroxytryptamine 1E antagonist | 0.257 0.067 DBMET02108 0.25 0.074 DB11091 0.257 0.067 DB09460 | DB09460 | |
| 0.028 | 0.013 | 0.036 | Lysophosphatidic acid receptor 1 agonist | 0.035 0.008 DBMET02108 0.036 0.007 DB11091 0.035 0.008 DB09460 | DB11091 | |
| 0.04 | 0.026 | 0.061 | GABA uptake inhibitor | 0.057 0.011 DBMET02108 0.061 0.01 DB11091 0.057 0.011 DB09460 | DB11091 | |
| 0.03 | 0.016 | 0.038 | Estrogen-related receptor gamma antagonist | 0.034 0.009 DBMET02108 0.038 0.006 DB11091 0.034 0.009 DB09460 | DB11091 | |
| 0.03 | 0.017 | 0.051 | Uridine phosphorylase inhibitor | 0.049 0.008 DBMET02108 0.051 0.008 DB11091 0.049 0.008 DB09460 | DB11091 | |
| 0.062 | 0.049 | 0.075 | Transcription factor RelA inhibitor | 0.075 0.022 DBMET02108 0.074 0.023 DB11091 0.075 0.022 DB09460 | DB09460 | |
| 0.089 | 0.076 | 0.137 | Carbonic anhydrase III inhibitor | 0.129 0.039 DBMET02108 0.137 0.034 DB11091 0.129 0.039 DB09460 | DB11091 | |
| 0.021 | 0.008 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DBMET02108 0.023 0.005 DB11091 0.023 0.005 DB09460 | DB09460 | |
| 0.104 | 0.093 | 0.203 | Amylase inhibitor | 0.188 0.048 DBMET02108 0.203 0.043 DB11091 0.188 0.048 DB09460 | DB11091 | |
| 0.024 | 0.013 | 0.05 | Glutamate (mGluR1a) agonist | 0.05 0.005 DBMET02108 0.049 0.005 DB11091 0.05 0.005 DB09460 | DB09460 | |
| 0.113 | 0.105 | 0.176 | Vanilloid 1 agonist | 0.176 0.02 DBMET02108 0.139 0.052 DB11091 0.176 0.02 DB09460 | DB09460 | |
| 0.016 | 0.007 | 0.025 | Lysophosphatidic acid receptor 3 agonist | 0.023 0.005 DBMET02108 0.025 0.004 DB11091 0.023 0.005 DB09460 | DB11091 | |
| 0.026 | 0.017 | 0.033 | Complement factor 1s inhibitor | 0.033 0.005 DBMET02108 0.032 0.006 DB11091 0.033 0.005 DB09460 | DB09460 | |
| 0.035 | 0.027 | 0.053 | Arginase inhibitor | 0.051 0.014 DBMET02108 0.053 0.013 DB11091 0.051 0.014 DB09460 | DB11091 | |
| 0.044 | 0.036 | 0.063 | Adenosine deaminase inhibitor | 0.06 0.021 DBMET02108 0.063 0.018 DB11091 0.06 0.021 DB09460 | DB11091 | |
| 0.026 | 0.019 | 0.038 | Nicotinic acid receptor 2 antagonist | 0.037 0.006 DBMET02108 0.038 0.006 DB11091 0.037 0.006 DB09460 | DB11091 | |
| 0.042 | 0.034 | 0.05 | Heme oxygenase inhibitor | 0.05 0.013 DBMET02108 0.05 0.013 DB11091 0.05 0.013 DB09460 | DB09460 | |
| 0.017 | 0.009 | 0.021 | Purinergic P2Y1 agonist | 0.019 0.007 DBMET02108 0.021 0.006 DB11091 0.019 0.007 DB09460 | DB11091 | |
| 0.057 | 0.049 | 0.094 | NMDA receptor glycine site agonist | 0.092 0.021 DBMET02108 0.094 0.019 DB11091 0.092 0.021 DB09460 | DB11091 | |
| 0.014 | 0.007 | 0.021 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET02108 0.021 0.004 DB11091 0.02 0.004 DB09460 | DB11091 | |
| 0.098 | 0.092 | 0.139 | Acetylcholine release stimulant | 0.139 0.024 DBMET02108 0.133 0.031 DB11091 0.139 0.024 DB09460 | DB09460 | |
| 0.047 | 0.041 | 0.065 | Squalene epoxidase inhibitor | 0.063 0.018 DBMET02108 0.065 0.017 DB11091 0.063 0.018 DB09460 | DB11091 | |
| 0.013 | 0.007 | 0.02 | Glutamate (mGluR6) agonist | 0.019 0.004 DBMET02108 0.02 0.004 DB11091 0.019 0.004 DB09460 | DB11091 | |
| 0.016 | 0.01 | 0.026 | Thromboxane A2 agonist | 0.026 0.004 DBMET02108 0.022 0.005 DB11091 0.026 0.004 DB09460 | DB09460 | |
| 0.028 | 0.023 | 0.042 | Nicotinic alpha3beta4 receptor agonist | 0.042 0.009 DBMET02108 0.041 0.009 DB11091 0.042 0.009 DB09460 | DB09460 | |
| 0.041 | 0.037 | 0.056 | AICAR transformylase inhibitor | 0.054 0.018 DBMET02108 0.056 0.017 DB11091 0.054 0.018 DB09460 | DB11091 | |
| 0.135 | 0.131 | 0.219 | 3C-like protease (Human coronavirus) inhibitor | 0.219 0.042 DBMET02108 0.201 0.051 DB11091 0.219 0.042 DB09460 | DB09460 | |
| 0.018 | 0.015 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 DBMET02108 0.023 0.006 DB11091 0.023 0.007 DB09460 | DB09460 | |
| 0.025 | 0.021 | 0.035 | Lysine carboxypeptidase inhibitor | 0.033 0.013 DBMET02108 0.035 0.013 DB11091 0.033 0.013 DB09460 | DB11091 | |
| 0.02 | 0.017 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 DBMET02108 0.026 0.007 DB11091 0.025 0.008 DB09460 | DB11091 | |
| 0.06 | 0.058 | 0.075 | Calcium channel P-type blocker | 0.073 0.022 DBMET02108 0.075 0.02 DB11091 0.073 0.022 DB09460 | DB11091 | |
| 0.02 | 0.018 | 0.025 | Retinoid X beta receptor antagonist | 0.024 0.008 DBMET02108 0.025 0.008 DB11091 0.024 0.008 DB09460 | DB11091 | |
| 0.1 | 0.098 | 0.163 | Aldehyde dehydrogenase inhibitor | 0.162 0.041 DBMET02108 0.163 0.04 DB11091 0.162 0.041 DB09460 | DB11091 | |
| 0.021 | 0.019 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.026 0.01 DBMET02108 0.027 0.008 DB11091 0.026 0.01 DB09460 | DB11091 | |
| 0.031 | 0.03 | 0.049 | Phosphoglycerate kinase inhibitor | 0.042 0.018 DBMET02108 0.049 0.014 DB11091 0.042 0.018 DB09460 | DB11091 | |
| 0.123 | 0.121 | 0.153 | Pregnane X receptor agonist | 0.152 0.05 DBMET02108 0.153 0.048 DB11091 0.152 0.05 DB09460 | DB11091 | |
| 0.025 | 0.024 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.031 0.01 DBMET02108 0.031 0.01 DB11091 0.031 0.01 DB09460 | DB09460 | |
| 0.052 | 0.051 | 0.077 | Carbonic anhydrase stimulant | 0.075 0.029 DBMET02108 0.077 0.027 DB11091 0.075 0.029 DB09460 | DB11091 | |
| 0.011 | 0.011 | 0.018 | Carbonic anhydrase XI inhibitor | 0.018 0.005 DBMET02108 0.017 0.005 DB11091 0.018 0.005 DB09460 | DB09460 | |
| 0.049 | 0.049 | 0.075 | Sphingosine kinase 2 inhibitor | 0.067 0.024 DBMET02108 0.075 0.018 DB11091 0.067 0.024 DB09460 | DB11091 | |
| 0.066 | 0.066 | 0.124 | CYP2A6 inhibitor | 0.124 0.025 DBMET02108 0.118 0.028 DB11091 0.124 0.025 DB09460 | DB09460 | |
| 0.007 | 0.007 | 0.01 | DNA topoisomerase III inhibitor | 0.009 0.004 DBMET02108 0.01 0.004 DB11091 0.009 0.004 DB09460 | DB11091 | |
| 0.02 | 0.02 | 0.028 | Prostaglandin F2 alpha agonist | 0.027 0.011 DBMET02108 0.028 0.01 DB11091 0.027 0.011 DB09460 | DB11091 | |
| 0.074 | 0.074 | 0.106 | Ornithine decarboxylase inhibitor | 0.104 0.04 DBMET02108 0.106 0.038 DB11091 0.104 0.04 DB09460 | DB11091 | |
| 0.086 | 0.086 | 0.148 | Falcipain 3 inhibitor | 0.148 0.038 DBMET02108 0.143 0.04 DB11091 0.148 0.038 DB09460 | DB09460 | |
| 0.024 | 0.024 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 DBMET02108 0.031 0.01 DB11091 0.031 0.011 DB09460 | DB09460 | |
| 0.036 | 0.037 | 0.051 | Thymidine kinase inhibitor | 0.05 0.019 DBMET02108 0.051 0.018 DB11091 0.05 0.019 DB09460 | DB11091 | |
| 0.057 | 0.059 | 0.082 | Protease 3C (Human rhinovirus) inhibitor | 0.082 0.026 DBMET02108 0.077 0.029 DB11091 0.082 0.026 DB09460 | DB09460 | |
| 0.058 | 0.059 | 0.106 | Interferon inducer | 0.106 0.01 DBMET02108 0.079 0.024 DB11091 0.106 0.01 DB09460 | DB09460 | |
| 0.055 | 0.056 | 0.091 | NMDA receptor agonist | 0.087 0.025 DBMET02108 0.091 0.023 DB11091 0.087 0.025 DB09460 | DB11091 | |
| 0.019 | 0.021 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.007 DBMET02108 0.025 0.007 DB11091 0.025 0.007 DB09460 | DB09460 | |
| 0.057 | 0.06 | 0.106 | Acetylcholine M5 receptor agonist | 0.106 0.017 DBMET02108 0.095 0.023 DB11091 0.106 0.017 DB09460 | DB09460 | |
| 0.015 | 0.018 | 0.023 | Nicotinic acid receptor 1 antagonist | 0.022 0.007 DBMET02108 0.023 0.006 DB11091 0.022 0.007 DB09460 | DB11091 | |
| 0.008 | 0.012 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET02108 0.01 0.008 DB11091 0.01 0.008 DB09460 | DB09460 | |
| 0.033 | 0.038 | 0.051 | Dihydropteroate synthase inhibitor | 0.049 0.018 DBMET02108 0.051 0.016 DB11091 0.049 0.018 DB09460 | DB11091 | |
| 0.034 | 0.041 | 0.046 | Vanilloid 3 antagonist | 0.046 0.012 DBMET02108 0.046 0.012 DB11091 0.046 0.012 DB09460 | DB09460 | |
| 0.004 | 0.011 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.004 DBMET02108 0.006 0.005 DB11091 0.006 0.004 DB09460 | DB09460 | |
| 0.029 | 0.036 | 0.04 | Retinoid X alpha receptor antagonist | 0.039 0.017 DBMET02108 0.04 0.015 DB11091 0.039 0.017 DB09460 | DB11091 | |
| 0.031 | 0.038 | 0.094 | Glutamate (mGluR3) antagonist | 0.094 0.004 DBMET02108 0.05 0.013 DB11091 0.094 0.004 DB09460 | DB09460 | |
| 0.032 | 0.04 | 0.045 | Retinoid X receptor antagonist | 0.043 0.019 DBMET02108 0.045 0.017 DB11091 0.043 0.019 DB09460 | DB11091 | |
| 0.025 | 0.034 | 0.034 | Calcitonin receptor agonist | 0.033 0.024 DBMET02108 0.034 0.024 DB11091 0.033 0.024 DB09460 | DB11091 | |
| 0.031 | 0.04 | 0.045 | Toll-Like receptor 2 agonist | 0.044 0.027 DBMET02108 0.045 0.026 DB11091 0.044 0.027 DB09460 | DB11091 | |
| 0.043 | 0.052 | 0.057 | Cytokine production stimulant | 0.056 0.018 DBMET02108 0.057 0.017 DB11091 0.056 0.018 DB09460 | DB11091 | |
| 0.031 | 0.041 | 0.042 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.013 DBMET02108 0.042 0.012 DB11091 0.041 0.013 DB09460 | DB11091 | |
| 0.012 | 0.022 | 0.016 | Aminopeptidase A inhibitor | 0.016 0.014 DB11091 | DB11091 | |
| 0.02 | 0.03 | 0.03 | Glutamate (mGluR1) agonist | 0.03 0.01 DBMET02108 0.03 0.01 DB11091 0.03 0.01 DB09460 | DB09460 | |
| 0.067 | 0.077 | 0.128 | Interferon agonist | 0.128 0.015 DBMET02108 0.095 0.033 DB11091 0.128 0.015 DB09460 | DB09460 | |
| 0.007 | 0.017 | 0.014 | Thromboxane agonist | 0.014 0.005 DBMET02108 0.011 0.008 DB11091 0.014 0.005 DB09460 | DB09460 | |
| 0.004 | 0.015 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET02108 0.006 0.005 DB11091 0.006 0.005 DB09460 | DB09460 | |
| 0.021 | 0.033 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.037 0.01 DBMET02108 0.035 0.012 DB11091 0.037 0.01 DB09460 | DB09460 | |
| 0.012 | 0.024 | 0.022 | Cyclin T1 inhibitor | 0.02 0.011 DBMET02108 0.022 0.009 DB11091 0.02 0.011 DB09460 | DB11091 | |
| 0.008 | 0.02 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 DB11091 | DB11091 | |
| 0.023 | 0.036 | 0.041 | Potassium channel small-conductance Ca-activated activator | 0.041 0.015 DBMET02108 0.039 0.015 DB11091 0.041 0.015 DB09460 | DB09460 | |
| 0.081 | 0.095 | 0.194 | Expectorant | 0.194 0.022 DBMET02108 0.122 0.05 DB11091 0.194 0.022 DB09460 | DB09460 | |
| 0.025 | 0.039 | 0.035 | ATP citrate lysase inhibitor | 0.033 0.021 DBMET02108 0.035 0.018 DB11091 0.033 0.021 DB09460 | DB11091 | |
| 0.01 | 0.025 | 0.014 | Cyclin D2 inhibitor | 0.014 0.007 DBMET02108 0.013 0.009 DB11091 0.014 0.007 DB09460 | DB09460 | |
| 0.102 | 0.116 | 0.141 | Sphingosine 1-phosphate receptor 4 antagonist | 0.138 0.045 DBMET02108 0.141 0.042 DB11091 0.138 0.045 DB09460 | DB11091 | |
| 0.025 | 0.04 | 0.043 | Retinoid X alpha receptor agonist | 0.04 0.019 DBMET02108 0.043 0.018 DB11091 0.04 0.019 DB09460 | DB11091 | |
| 0.011 | 0.027 | 0.021 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET02108 0.021 0.009 DB11091 0.018 0.011 DB09460 | DB11091 | |
| 0.021 | 0.037 | 0.031 | Acid ceramidase inhibitor | 0.031 0.008 DBMET02108 0.028 0.012 DB11091 0.031 0.008 DB09460 | DB09460 | |
| 0.036 | 0.052 | 0.054 | Glutamate (mGluR4) antagonist | 0.053 0.018 DBMET02108 0.054 0.017 DB11091 0.053 0.018 DB09460 | DB11091 | |
| 0.05 | 0.066 | 0.059 | Leukotriene C antagonist | 0.058 0.035 DBMET02108 0.059 0.032 DB11091 0.058 0.035 DB09460 | DB11091 | |
| 0.021 | 0.037 | 0.029 | Integrin alpha2beta1 antagonist | 0.028 0.015 DBMET02108 0.029 0.014 DB11091 0.028 0.015 DB09460 | DB11091 | |
| 0.016 | 0.033 | 0.023 | Factor XIII inhibitor | 0.023 0.01 DBMET02108 0.021 0.014 DB11091 0.023 0.01 DB09460 | DB09460 | |
| 0.041 | 0.058 | 0.061 | Potassium channel (Inward rectifier) activator | 0.061 0.019 DBMET02108 0.061 0.019 DB11091 0.061 0.019 DB09460 | DB09460 | |
| 0.04 | 0.057 | 0.058 | Potassium channel (ATP-sensitive) activator | 0.058 0.018 DBMET02108 0.058 0.018 DB11091 0.058 0.018 DB09460 | DB09460 | |
| 0.022 | 0.04 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | 0.032 0.019 DBMET02108 0.037 0.015 DB11091 0.032 0.019 DB09460 | DB11091 | |
| 0.026 | 0.045 | 0.034 | Carboxypeptidase B inhibitor | 0.034 0.02 DBMET02108 0.032 0.025 DB11091 0.034 0.02 DB09460 | DB09460 | |
| 0.014 | 0.032 | 0.018 | Estrogen-related receptor gamma agonist | 0.017 0.016 DBMET02108 0.018 0.014 DB11091 0.017 0.016 DB09460 | DB11091 | |
| 0.019 | 0.038 | 0.045 | Sodium/glucose cotransporter 2 inhibitor | 0.045 0.007 DBMET02108 0.028 0.015 DB11091 0.045 0.007 DB09460 | DB09460 | |
| 0.064 | 0.084 | 0.102 | Carbonic anhydrase VI inhibitor | 0.095 0.042 DBMET02108 0.102 0.038 DB11091 0.095 0.042 DB09460 | DB11091 | |
| 0.027 | 0.047 | 0.053 | Ceramide glucosyltransferase inhibitor | 0.053 0.005 DBMET02108 0.04 0.018 DB11091 0.053 0.005 DB09460 | DB09460 | |
| 0.04 | 0.059 | 0.05 | Bombesin 2 receptor antagonist | 0.049 0.034 DBMET02108 0.05 0.033 DB11091 0.049 0.034 DB09460 | DB11091 | |
| 0.038 | 0.058 | 0.077 | Carbonic anhydrase VB inhibitor | 0.073 0.026 DBMET02108 0.077 0.024 DB11091 0.073 0.026 DB09460 | DB11091 | |
| 0.044 | 0.063 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | 0.063 0.023 DBMET02108 0.062 0.024 DB11091 0.063 0.023 DB09460 | DB09460 | |
| 0.05 | 0.07 | 0.101 | 5 Hydroxytryptamine 3 agonist | 0.101 0.015 DBMET02108 0.079 0.027 DB11091 0.101 0.015 DB09460 | DB09460 | |
| 0.051 | 0.071 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.021 DBMET02108 0.073 0.025 DB11091 0.076 0.021 DB09460 | DB09460 | |
| 0.023 | 0.043 | 0.037 | Epoxide hydrolase 1 inhibitor | 0.037 0.014 DBMET02108 0.033 0.018 DB11091 0.037 0.014 DB09460 | DB09460 | |
| 0.06 | 0.08 | 0.076 | MDM2 inhibitor | 0.076 0.026 DBMET02108 0.076 0.025 DB11091 0.076 0.026 DB09460 | DB09460 | |
| 0.027 | 0.048 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.016 DBMET02108 0.037 0.015 DB11091 0.037 0.016 DB09460 | DB09460 | |
| 0.017 | 0.038 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.023 0.017 DBMET02108 0.025 0.013 DB11091 0.023 0.017 DB09460 | DB11091 | |
| 0.02 | 0.042 | 0.032 | Peptide deformylase inhibitor | 0.03 0.021 DBMET02108 0.032 0.019 DB11091 0.03 0.021 DB09460 | DB11091 | |
| 0.03 | 0.052 | 0.046 | Potassium channel Kv1.1 blocker | 0.046 0.016 DBMET02108 0.041 0.021 DB11091 0.046 0.016 DB09460 | DB09460 | |
| 0.034 | 0.057 | 0.042 | CF transmembrane conductance regulator antagonist | 0.041 0.024 DBMET02108 0.042 0.019 DB11091 0.041 0.024 DB09460 | DB11091 | |
| 0.1 | 0.122 | 0.158 | Protein kinase stimulant | 0.151 0.068 DBMET02108 0.158 0.063 DB11091 0.151 0.068 DB09460 | DB11091 | |
| 0.028 | 0.051 | 0.04 | Integrin alpha2 antagonist | 0.038 0.023 DBMET02108 0.04 0.021 DB11091 0.038 0.023 DB09460 | DB11091 | |
| 0.023 | 0.047 | 0.038 | Free fatty acid receptor 1 antagonist | 0.036 0.02 DBMET02108 0.038 0.018 DB11091 0.036 0.02 DB09460 | DB11091 | |
| 0.01 | 0.034 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.011 DBMET02108 0.016 0.012 DB11091 0.016 0.011 DB09460 | DB09460 | |
| 0.022 | 0.046 | 0.031 | MAP3K8 inhibitor | 0.031 0.017 DBMET02108 0.031 0.017 DB11091 0.031 0.017 DB09460 | DB09460 | |
| 0.063 | 0.086 | 0.084 | Potassium channel (Tandem pore domain) blocker | 0.084 0.026 DBMET02108 0.081 0.032 DB11091 0.084 0.026 DB09460 | DB09460 | |
| 0.056 | 0.08 | 0.092 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.089 0.044 DBMET02108 0.092 0.042 DB11091 0.089 0.044 DB09460 | DB11091 | |
| 0.009 | 0.033 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 DB11091 | DB11091 | |
| 0.013 | 0.038 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.013 DBMET02108 0.022 0.013 DB11091 0.022 0.013 DB09460 | DB09460 | |
| 0.026 | 0.051 | 0.037 | Melatonin receptor 1A agonist | 0.037 0.018 DBMET02108 0.034 0.021 DB11091 0.037 0.018 DB09460 | DB09460 | |
| 0.032 | 0.059 | 0.05 | Dihydroorotase inhibitor | 0.049 0.026 DBMET02108 0.05 0.024 DB11091 0.049 0.026 DB09460 | DB11091 | |
| 0.038 | 0.066 | 0.056 | Topoisomerase II beta inhibitor | 0.055 0.027 DBMET02108 0.056 0.025 DB11091 0.055 0.027 DB09460 | DB11091 | |
| 0.021 | 0.049 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 DBMET02108 0.028 0.022 DB11091 0.027 0.023 DB09460 | DB11091 | |
| 0.019 | 0.048 | 0.041 | Retinoid X receptor agonist | 0.038 0.024 DBMET02108 0.041 0.022 DB11091 0.038 0.024 DB09460 | DB11091 | |
| 0.035 | 0.063 | 0.051 | Glutamate (mGluR group III) antagonist | 0.05 0.021 DBMET02108 0.051 0.02 DB11091 0.05 0.021 DB09460 | DB11091 | |
| 0.022 | 0.05 | 0.031 | Glucosylceramidase stimulant | 0.031 0.011 DBMET02108 0.028 0.017 DB11091 0.031 0.011 DB09460 | DB09460 | |
| 0.032 | 0.061 | 0.038 | Leukotriene C4 antagonist | 0.037 0.032 DBMET02108 0.038 0.03 DB11091 0.037 0.032 DB09460 | DB11091 | |
| 0.071 | 0.099 | 0.113 | Alcohol dehydrogenase inhibitor | 0.108 0.044 DBMET02108 0.113 0.04 DB11091 0.108 0.044 DB09460 | DB11091 | |
| 0.042 | 0.071 | 0.065 | Heparanase inhibitor | 0.065 0.016 DBMET02108 0.056 0.03 DB11091 0.065 0.016 DB09460 | DB09460 | |
| 0.028 | 0.058 | 0.037 | Adenosine uptake inhibitor | 0.037 0.017 DBMET02108 0.036 0.021 DB11091 0.037 0.017 DB09460 | DB09460 | |
| 0.014 | 0.044 | 0.025 | Protease (Human cytomegalovirus) inhibitor | 0.025 0.011 DBMET02108 0.022 0.015 DB11091 0.025 0.011 DB09460 | DB09460 | |
| 0.013 | 0.043 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.016 DBMET02108 0.018 0.014 DB11091 0.018 0.016 DB09460 | DB09460 | |
| 0.019 | 0.049 | 0.038 | Sodium/glucose cotransporter inhibitor | 0.038 0.008 DBMET02108 0.025 0.018 DB11091 0.038 0.008 DB09460 | DB09460 | |
| 0.012 | 0.042 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.015 DBMET02108 0.016 0.015 DB09460 | DB09460 | |
| 0.102 | 0.133 | 0.256 | Cell wall synthesis inhibitor | 0.256 0.015 DBMET02108 0.171 0.046 DB11091 0.256 0.015 DB09460 | DB09460 | |
| 0.042 | 0.074 | 0.063 | Epithelial sodium channel blocker | 0.063 0.025 DBMET02108 0.061 0.027 DB11091 0.063 0.025 DB09460 | DB09460 | |
| 0.045 | 0.077 | 0.094 | Sphingosine 1-phosphate receptor 4 agonist | 0.088 0.031 DBMET02108 0.094 0.028 DB11091 0.088 0.031 DB09460 | DB11091 | |
| 0.047 | 0.08 | 0.075 | Potassium channel intermediate-conductance Ca-activated blocker | 0.075 0.022 DBMET02108 0.071 0.026 DB11091 0.075 0.022 DB09460 | DB09460 | |
| 0.031 | 0.065 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | 0.046 0.029 DBMET02108 0.05 0.024 DB11091 0.046 0.029 DB09460 | DB11091 | |
| 0.041 | 0.076 | 0.069 | Androgen agonist | 0.067 0.034 DBMET02108 0.069 0.031 DB11091 0.067 0.034 DB09460 | DB11091 | |
| 0.028 | 0.064 | 0.041 | AMPA 4 receptor antagonist | 0.039 0.028 DBMET02108 0.041 0.025 DB11091 0.039 0.028 DB09460 | DB11091 | |
| 0.026 | 0.062 | 0.041 | Delayed rectifier potassium channel blocker | 0.041 0.019 DBMET02108 0.039 0.023 DB11091 0.041 0.019 DB09460 | DB09460 | |
| 0.042 | 0.077 | 0.064 | Glucosylceramidase inhibitor | 0.056 0.036 DBMET02108 0.064 0.027 DB11091 0.056 0.036 DB09460 | DB11091 | |
| 0.045 | 0.081 | 0.065 | Sphingosine kinase inhibitor | 0.06 0.038 DBMET02108 0.065 0.031 DB11091 0.06 0.038 DB09460 | DB11091 | |
| 0.037 | 0.075 | 0.06 | HCV NS3/NS4A protease inhibitor | 0.06 0.021 DBMET02108 0.049 0.034 DB11091 0.06 0.021 DB09460 | DB09460 | |
| 0.034 | 0.072 | 0.074 | Aldosterone antagonist | 0.074 0.013 DBMET02108 0.053 0.026 DB11091 0.074 0.013 DB09460 | DB09460 | |
| 0.01 | 0.048 | 0.022 | Prostaglandin H2 antagonist | 0.022 0.021 DB11091 | DB11091 | |
| 0.011 | 0.049 | 0.018 | Complement factor D inhibitor | 0.018 0.012 DBMET02108 0.018 0.014 DB11091 0.018 0.012 DB09460 | DB09460 | |
| 0.047 | 0.087 | 0.077 | Carbonic anhydrase VA inhibitor | 0.076 0.04 DBMET02108 0.077 0.039 DB11091 0.076 0.04 DB09460 | DB11091 | |
| 0.084 | 0.125 | 0.188 | TRPA1 agonist | 0.188 0.013 DBMET02108 0.127 0.051 DB11091 0.188 0.013 DB09460 | DB09460 | |
| 0.075 | 0.115 | 0.1 | Bile acid receptor antagonist | 0.098 0.053 DBMET02108 0.1 0.049 DB11091 0.098 0.053 DB09460 | DB11091 | |
| 0.051 | 0.092 | 0.065 | Histone deacetylase SIRT3 inhibitor | 0.065 0.037 DBMET02108 0.062 0.044 DB11091 0.065 0.037 DB09460 | DB09460 | |
| 0.029 | 0.07 | 0.043 | Sphingosine kinase 1 inhibitor | 0.039 0.032 DBMET02108 0.043 0.026 DB11091 0.039 0.032 DB09460 | DB11091 | |
| 0.012 | 0.056 | 0.02 | Caspase 8 inhibitor | 0.02 0.014 DBMET02108 0.02 0.014 DB09460 | DB09460 | |
| 0.021 | 0.064 | 0.04 | Diamine oxidase inhibitor | 0.04 0.023 DBMET02108 0.04 0.023 DB11091 0.04 0.023 DB09460 | DB09460 | |
| 0.027 | 0.07 | 0.071 | Antimetabolite | 0.071 0.021 DBMET02108 0.042 0.038 DB11091 0.071 0.021 DB09460 | DB09460 | |
| 0.062 | 0.107 | 0.088 | Glutathione S-transferase inhibitor | 0.088 0.05 DBMET02108 0.088 0.049 DB11091 0.088 0.05 DB09460 | DB09460 | |
| 0.012 | 0.057 | 0.043 | Kynurenine 3 monooxygenase inhibitor | 0.043 0.009 DBMET02108 0.023 0.022 DB11091 0.043 0.009 DB09460 | DB09460 | |
| 0.121 | 0.166 | 0.257 | ATPase inhibitor | 0.257 0.012 DBMET02108 0.182 0.056 DB11091 0.257 0.012 DB09460 | DB09460 | |
| 0.103 | 0.149 | 0.168 | Hexokinase inhibitor | 0.162 0.066 DBMET02108 0.168 0.06 DB11091 0.162 0.066 DB09460 | DB11091 | |
| 0.021 | 0.067 | 0.03 | Dipeptidyl peptidase II inhibitor | 0.03 0.026 DBMET02108 0.03 0.026 DB09460 | DB09460 | |
| 0.023 | 0.07 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.029 DBMET02108 0.032 0.027 DB11091 0.032 0.029 DB09460 | DB09460 | |
| 0.027 | 0.073 | 0.068 | Thymidylate synthase inhibitor | 0.068 0.013 DBMET02108 0.049 0.029 DB11091 0.068 0.013 DB09460 | DB09460 | |
| 0.038 | 0.085 | 0.047 | CD45 antagonist | 0.047 0.042 DBMET02108 0.047 0.041 DB11091 0.047 0.042 DB09460 | DB09460 | |
| 0.046 | 0.094 | 0.087 | Carbonic anhydrase XIII inhibitor | 0.084 0.047 DBMET02108 0.087 0.045 DB11091 0.084 0.047 DB09460 | DB11091 | |
| 0.026 | 0.074 | 0.072 | Ribonucleoside-diphosphate reductase inhibitor | 0.072 0.028 DBMET02108 0.072 0.028 DB09460 | DB09460 | |
| 0.167 | 0.216 | 0.281 | Vasodilator, coronary | 0.278 0.107 DBMET02108 0.281 0.104 DB11091 0.278 0.107 DB09460 | DB11091 | |
| 0.025 | 0.075 | 0.074 | Ribonucleotide reductase inhibitor | 0.074 0.029 DBMET02108 0.074 0.029 DB09460 | DB09460 | |
| 0.017 | 0.067 | 0.033 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.021 DBMET02108 0.032 0.022 DB11091 0.033 0.021 DB09460 | DB09460 | |
| 0.012 | 0.062 | 0.032 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.032 0.015 DBMET02108 0.032 0.015 DB09460 | DB09460 | |
| 0.04 | 0.09 | 0.073 | Carbonic anhydrase V inhibitor | 0.07 0.042 DBMET02108 0.073 0.04 DB11091 0.07 0.042 DB09460 | DB11091 | |
| 0.037 | 0.087 | 0.089 | Cyclin-dependent kinase 6 inhibitor | 0.089 0.015 DBMET02108 0.062 0.039 DB11091 0.089 0.015 DB09460 | DB09460 | |
| 0.027 | 0.077 | 0.038 | 5 Hydroxytryptamine 2B agonist | 0.038 0.028 DBMET02108 0.038 0.029 DB11091 0.038 0.028 DB09460 | DB09460 | |
| 0.027 | 0.078 | 0.065 | Carbonic anhydrase I inhibitor | 0.065 0.032 DB11091 | DB11091 | |
| 0.015 | 0.067 | 0.035 | Kainate receptor 2 antagonist | 0.033 0.028 DBMET02108 0.035 0.025 DB11091 0.033 0.028 DB09460 | DB11091 | |
| 0.09 | 0.143 | 0.125 | Transcription factor STAT6 inhibitor | 0.124 0.054 DBMET02108 0.125 0.051 DB11091 0.124 0.054 DB09460 | DB11091 | |
| 0.039 | 0.093 | 0.058 | Botulinum neurotoxin type A inhibitor | 0.054 0.048 DBMET02108 0.058 0.041 DB11091 0.054 0.048 DB09460 | DB11091 | |
| 0.033 | 0.087 | 0.07 | Prolyl endopeptidase inhibitor | 0.07 0.016 DBMET02108 0.049 0.037 DB11091 0.07 0.016 DB09460 | DB09460 | |
| 0.037 | 0.092 | 0.056 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 DBMET02108 0.056 0.044 DB11091 0.054 0.047 DB09460 | DB11091 | |
| 0.031 | 0.086 | 0.047 | Purinergic P2X4 antagonist | 0.047 0.03 DBMET02108 0.045 0.033 DB11091 0.047 0.03 DB09460 | DB09460 | |
| 0.095 | 0.151 | 0.128 | DNA repair enzyme inhibitor | 0.126 0.061 DBMET02108 0.128 0.058 DB11091 0.126 0.061 DB09460 | DB11091 | |
| 0.048 | 0.106 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.06 0.056 DBMET02108 0.064 0.046 DB11091 0.06 0.056 DB09460 | DB11091 | |
| 0.048 | 0.106 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | 0.089 0.041 DBMET02108 0.088 0.042 DB11091 0.089 0.041 DB09460 | DB09460 | |
| 0.029 | 0.088 | 0.043 | GABA B receptor antagonist | 0.042 0.032 DBMET02108 0.043 0.029 DB11091 0.042 0.032 DB09460 | DB11091 | |
| 0.025 | 0.084 | 0.063 | Carbonic anhydrase II inhibitor | 0.063 0.033 DB11091 | DB11091 | |
| 0.012 | 0.072 | 0.029 | Glutaminyl-peptide cyclotransferase inhibitor | 0.029 0.007 DBMET02108 0.029 0.007 DB09460 | DB09460 | |
| 0.063 | 0.124 | 0.143 | Gastric antisecretory | 0.143 0.03 DBMET02108 0.136 0.034 DB11091 0.143 0.03 DB09460 | DB09460 | |
| 0.029 | 0.089 | 0.048 | CC chemokine 4 receptor antagonist | 0.048 0.031 DBMET02108 0.048 0.031 DB11091 0.048 0.031 DB09460 | DB09460 | |
| 0.045 | 0.106 | 0.072 | Cathepsin G inhibitor | 0.072 0.051 DBMET02108 0.071 0.052 DB11091 0.072 0.051 DB09460 | DB09460 | |
| 0.044 | 0.105 | 0.065 | Aryl hydrocarbon receptor antagonist | 0.065 0.044 DBMET02108 0.064 0.047 DB11091 0.065 0.044 DB09460 | DB09460 | |
| 0.011 | 0.073 | 0.03 | Acetylcholine M4 receptor agonist | 0.03 0.022 DBMET02108 0.03 0.022 DB09460 | DB09460 | |
| 0.05 | 0.112 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.047 DBMET02108 0.061 0.046 DB11091 0.061 0.047 DB09460 | DB09460 | |
| 0.074 | 0.136 | 0.099 | Phosphodiesterase 6D inhibitor | 0.099 0.055 DBMET02108 0.099 0.054 DB11091 0.099 0.055 DB09460 | DB09460 | |
| 0.065 | 0.127 | 0.102 | Bromodomain-containing protein 2 inhibitor | 0.102 0.038 DBMET02108 0.097 0.045 DB11091 0.102 0.038 DB09460 | DB09460 | |
| 0.036 | 0.098 | 0.06 | Sphingosine 1-phosphate receptor 3 antagonist | 0.058 0.042 DBMET02108 0.06 0.038 DB11091 0.058 0.042 DB09460 | DB11091 | |
| 0.026 | 0.09 | 0.041 | Glutamate (mGluR group III) agonist | 0.041 0.033 DBMET02108 0.041 0.032 DB11091 0.041 0.033 DB09460 | DB09460 | |
| 0.072 | 0.136 | 0.102 | Beta glucuronidase inhibitor | 0.099 0.071 DBMET02108 0.102 0.067 DB11091 0.099 0.071 DB09460 | DB11091 | |
| 0.047 | 0.113 | 0.101 | Calcium antagonist | 0.101 0.047 DBMET02108 0.094 0.052 DB11091 0.101 0.047 DB09460 | DB09460 | |
| 0.038 | 0.105 | 0.054 | 5 Hydroxytryptamine 7 agonist | 0.054 0.043 DBMET02108 0.053 0.047 DB11091 0.054 0.043 DB09460 | DB09460 | |
| 0.035 | 0.104 | 0.064 | Cyclin D1 inhibitor | 0.064 0.036 DBMET02108 0.062 0.04 DB11091 0.064 0.036 DB09460 | DB09460 | |
| 0.021 | 0.089 | 0.057 | Angiotensin AT1 receptor antagonist | 0.057 0.009 DBMET02108 0.041 0.032 DB11091 0.057 0.009 DB09460 | DB09460 | |
| 0.022 | 0.093 | 0.037 | MAP3K5 inhibitor | 0.037 0.03 DBMET02108 0.037 0.031 DB11091 0.037 0.03 DB09460 | DB09460 | |
| 0.066 | 0.139 | 0.128 | Adenylate cyclase inhibitor | 0.122 0.066 DBMET02108 0.128 0.061 DB11091 0.122 0.066 DB09460 | DB11091 | |
| 0.014 | 0.087 | 0.046 | Nicotinic acid receptor agonist | 0.046 0.016 DBMET02108 0.033 0.029 DB11091 0.046 0.016 DB09460 | DB09460 | |
| 0.027 | 0.102 | 0.073 | Cannabinoid CB1 receptor agonist | 0.073 0.033 DB11091 | DB11091 | |
| 0.027 | 0.102 | 0.07 | Carbonic anhydrase inhibitor | 0.062 0.045 DBMET02108 0.07 0.04 DB11091 0.062 0.045 DB09460 | DB11091 | |
| 0.055 | 0.132 | 0.071 | Estrogen receptor alpha antagonist | 0.071 0.066 DB11091 | DB11091 | |
| 0.038 | 0.115 | 0.109 | Glutamate receptor agonist | 0.092 0.043 DBMET02108 0.109 0.031 DB11091 0.092 0.043 DB09460 | DB11091 | |
| 0.151 | 0.228 | 0.21 | Neuropeptide Y2 antagonist | 0.21 0.103 DBMET02108 0.207 0.107 DB11091 0.21 0.103 DB09460 | DB09460 | |
| 0.018 | 0.096 | 0.047 | Angiotensin II receptor antagonist | 0.047 0.008 DBMET02108 0.047 0.008 DB09460 | DB09460 | |
| 0.054 | 0.132 | 0.103 | Urease inhibitor | 0.102 0.064 DBMET02108 0.103 0.063 DB11091 0.102 0.064 DB09460 | DB11091 | |
| 0.021 | 0.1 | 0.079 | Potassium channel Kv1.3 blocker | 0.079 0.012 DBMET02108 0.079 0.012 DB09460 | DB09460 | |
| 0.106 | 0.186 | 0.138 | MAP kinase 3 inhibitor | 0.136 0.092 DBMET02108 0.138 0.089 DB11091 0.136 0.092 DB09460 | DB11091 | |
| 0.065 | 0.146 | 0.11 | MAP kinase kinase 1 inhibitor | 0.11 0.045 DBMET02108 0.105 0.05 DB11091 0.11 0.045 DB09460 | DB09460 | |
| 0.007 | 0.088 | 0.029 | Dopamine autoreceptor agonist | 0.029 0.014 DBMET02108 0.029 0.014 DB09460 | DB09460 | |
| 0.154 | 0.236 | 0.462 | Vasodilator, peripheral | 0.462 0.037 DBMET02108 0.281 0.107 DB11091 0.462 0.037 DB09460 | DB09460 | |
| 0.024 | 0.106 | 0.044 | Glutamate (mGluR5) agonist | 0.044 0.034 DBMET02108 0.044 0.034 DB09460 | DB09460 | |
| 0.013 | 0.096 | 0.026 | LFA antagonist | 0.026 0.022 DBMET02108 0.026 0.022 DB09460 | DB09460 | |
| 0.167 | 0.25 | 0.355 | 15-Lipoxygenase inhibitor | 0.207 0.206 DBMET02108 0.355 0.096 DB11091 0.207 0.206 DB09460 | DB11091 | |
| 0.016 | 0.1 | 0.037 | Vascular adhesion protein 1 inhibitor | 0.037 0.03 DBMET02108 0.036 0.032 DB11091 0.037 0.03 DB09460 | DB09460 | |
| 0.013 | 0.098 | 0.061 | Calcium-sensing receptor agonist | 0.061 0.005 DBMET02108 0.061 0.005 DB09460 | DB09460 | |
| 0.041 | 0.126 | 0.059 | Phosphodiesterase 1A inhibitor | 0.059 0.044 DBMET02108 0.057 0.05 DB11091 0.059 0.044 DB09460 | DB09460 | |
| 0.013 | 0.1 | 0.027 | CDK4/cyclin D3 inhibitor | 0.027 0.023 DBMET02108 0.027 0.023 DB09460 | DB09460 | |
| 0.107 | 0.194 | 0.241 | Insulin sensitizer | 0.241 0.04 DBMET02108 0.178 0.098 DB11091 0.241 0.04 DB09460 | DB09460 | |
| 0.047 | 0.134 | 0.088 | Myeloperoxidase inhibitor | 0.085 0.057 DBMET02108 0.088 0.053 DB11091 0.085 0.057 DB09460 | DB11091 | |
| 0.014 | 0.101 | 0.046 | Cholesterol ester transfer protein antagonist | 0.046 0.009 DBMET02108 0.046 0.009 DB09460 | DB09460 | |
| 0.02 | 0.11 | 0.041 | Glutamate (mGluR1a) antagonist | 0.041 0.028 DBMET02108 0.041 0.028 DB09460 | DB09460 | |
| 0.027 | 0.117 | 0.046 | Cholesterol esterase inhibitor | 0.046 0.036 DBMET02108 0.043 0.041 DB11091 0.046 0.036 DB09460 | DB09460 | |
| 0.017 | 0.108 | 0.057 | Cannabinoid CB2 receptor antagonist | 0.057 0.032 DB11091 | DB11091 | |
| 0.021 | 0.112 | 0.076 | Xanthine dehydrogenase inhibitor | 0.076 0.027 DBMET02108 0.076 0.027 DB09460 | DB09460 | |
| 0.063 | 0.155 | 0.125 | Xanthine oxidase inhibitor | 0.125 0.045 DBMET02108 0.086 0.078 DB11091 0.125 0.045 DB09460 | DB09460 | |
| 0.121 | 0.216 | 0.202 | Cyclic AMP phosphodiesterase inhibitor | 0.202 0.092 DBMET02108 0.2 0.094 DB11091 0.202 0.092 DB09460 | DB09460 | |
| 0.023 | 0.12 | 0.056 | NMDA 2C receptor antagonist | 0.056 0.05 DB11091 | DB11091 | |
| 0.016 | 0.114 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.041 0.016 DBMET02108 0.041 0.016 DB09460 | DB09460 | |
| 0.042 | 0.141 | 0.059 | Phosphodiesterase 1C inhibitor | 0.058 0.053 DBMET02108 0.059 0.05 DB11091 0.058 0.053 DB09460 | DB11091 | |
| 0.068 | 0.167 | 0.143 | Nav1.6 sodium channel blocker | 0.142 0.063 DBMET02108 0.143 0.063 DB11091 0.142 0.063 DB09460 | DB11091 | |
| 0.054 | 0.156 | 0.087 | Caspase 7 inhibitor | 0.087 0.047 DBMET02108 0.083 0.054 DB11091 0.087 0.047 DB09460 | DB09460 | |
| 0.1 | 0.203 | 0.175 | I kappa B kinase epsilon inhibitor | 0.175 0.094 DBMET02108 0.174 0.095 DB11091 0.175 0.094 DB09460 | DB09460 | |
| 0.025 | 0.129 | 0.045 | Benzodiazepine antagonist | 0.045 0.039 DBMET02108 0.045 0.039 DB09460 | DB09460 | |
| 0.036 | 0.14 | 0.056 | Heat shock protein 90 beta antagonist | 0.056 0.046 DB11091 | DB11091 | |
| 0.034 | 0.14 | 0.085 | Protein kinase C beta inhibitor | 0.085 0.024 DBMET02108 0.069 0.049 DB11091 0.085 0.024 DB09460 | DB09460 | |
| 0.021 | 0.128 | 0.048 | Dihydrofolate reductase inhibitor | 0.048 0.021 DBMET02108 0.048 0.021 DB09460 | DB09460 | |
| 0.104 | 0.213 | 0.255 | Immunostimulant | 0.255 0.094 DBMET02108 0.184 0.13 DB11091 0.255 0.094 DB09460 | DB09460 | |
| 0.031 | 0.14 | 0.087 | Fatty acid synthase inhibitor | 0.087 0.015 DBMET02108 0.087 0.015 DB09460 | DB09460 | |
| 0.015 | 0.125 | 0.042 | Glutamate (mGluR group I) agonist | 0.042 0.04 DBMET02108 0.042 0.04 DB09460 | DB09460 | |
| 0.025 | 0.136 | 0.053 | Matrix metalloproteinase (membrane-type) inhibitor | 0.053 0.042 DBMET02108 0.053 0.042 DB09460 | DB09460 | |
| 0.02 | 0.132 | 0.06 | Neutrophil collagenase inhibitor | 0.06 0.051 DBMET02108 0.06 0.051 DB09460 | DB09460 | |
| 0.028 | 0.141 | 0.061 | Cannabinoid CB1 receptor antagonist | 0.061 0.044 DB11091 | DB11091 | |
| 0.011 | 0.124 | 0.033 | Glutamate (mGluR2) antagonist | 0.033 0.017 DBMET02108 0.033 0.017 DB09460 | DB09460 | |
| 0.058 | 0.171 | 0.083 | Protein kinase C zeta inhibitor | 0.082 0.081 DBMET02108 0.083 0.079 DB11091 0.082 0.081 DB09460 | DB11091 | |
| 0.074 | 0.189 | 0.111 | Interleukin 8 antagonist | 0.107 0.081 DBMET02108 0.111 0.074 DB11091 0.107 0.081 DB09460 | DB11091 | |
| 0.02 | 0.136 | 0.063 | Thromboxane antagonist | 0.063 0.03 DBMET02108 0.063 0.03 DB09460 | DB09460 | |
| 0.059 | 0.176 | 0.134 | Proteasome inhibitor | 0.134 0.056 DBMET02108 0.099 0.088 DB11091 0.134 0.056 DB09460 | DB09460 | |
| 0.015 | 0.132 | 0.046 | Glutamate (mGluR group II) antagonist | 0.046 0.019 DBMET02108 0.046 0.019 DB09460 | DB09460 | |
| 0.024 | 0.145 | 0.067 | Nicotinic receptor alpha7 subunit antagonist | 0.067 0.023 DBMET02108 0.067 0.023 DB09460 | DB09460 | |
| 0.024 | 0.147 | 0.067 | Histamine agonist | 0.067 0.022 DBMET02108 0.067 0.022 DB09460 | DB09460 | |
| 0.058 | 0.183 | 0.102 | Protein kinase C gamma inhibitor | 0.102 0.074 DBMET02108 0.1 0.077 DB11091 0.102 0.074 DB09460 | DB09460 | |
| 0.011 | 0.138 | 0.03 | Liver X receptor beta agonist | 0.03 0.028 DBMET02108 0.03 0.028 DB09460 | DB09460 | |
| 0.016 | 0.143 | 0.053 | Aromatase inhibitor | 0.053 0.046 DBMET02108 0.053 0.046 DB09460 | DB09460 | |
| 0.014 | 0.142 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 DBMET02108 0.056 0.027 DB09460 | DB09460 | |
| 0.024 | 0.153 | 0.213 | Antineoplastic antibiotic | 0.213 0.019 DB11091 | DB11091 | |
| 0.016 | 0.148 | 0.032 | RNA-directed RNA polymerase inhibitor | 0.032 0.027 DBMET02108 0.032 0.027 DB09460 | DB09460 | |
| 0.054 | 0.189 | 0.107 | Interleukin 1 beta converting enzyme inhibitor | 0.107 0.048 DBMET02108 0.091 0.07 DB11091 0.107 0.048 DB09460 | DB09460 | |
| 0.046 | 0.18 | 0.076 | Histamine H2 receptor antagonist | 0.076 0.074 DBMET02108 0.076 0.074 DB09460 | DB09460 | |
| 0.017 | 0.154 | 0.066 | Leukocyte elastase inhibitor | 0.066 0.016 DBMET02108 0.066 0.016 DB09460 | DB09460 | |
| 0.024 | 0.162 | 0.094 | Alpha 2 adrenoreceptor agonist | 0.094 0.017 DBMET02108 0.094 0.017 DB09460 | DB09460 | |
| 0.042 | 0.18 | 0.177 | Anesthetic local | 0.177 0.039 DBMET02108 0.177 0.039 DB09460 | DB09460 | |
| 0.058 | 0.196 | 0.126 | Caspase 3 inhibitor | 0.126 0.051 DBMET02108 0.105 0.083 DB11091 0.126 0.051 DB09460 | DB09460 | |
| 0.036 | 0.179 | 0.071 | Metalloproteinase-9 inhibitor | 0.071 0.054 DBMET02108 0.071 0.054 DB09460 | DB09460 | |
| 0.085 | 0.23 | 0.166 | MAP kinase kinase 2 inhibitor | 0.166 0.107 DBMET02108 0.166 0.107 DB11091 0.166 0.107 DB09460 | DB09460 | |
| 0.036 | 0.182 | 0.073 | Secretase beta inhibitor | 0.073 0.045 DBMET02108 0.065 0.059 DB11091 0.073 0.045 DB09460 | DB09460 | |
| 0.017 | 0.162 | 0.054 | Dihydroorotate dehydrogenase inhibitor | 0.054 0.033 DBMET02108 0.054 0.033 DB09460 | DB09460 | |
| 0.113 | 0.259 | 0.234 | Lipoxygenase inhibitor | 0.22 0.122 DBMET02108 0.234 0.111 DB11091 0.22 0.122 DB09460 | DB11091 | |
| 0.035 | 0.183 | 0.171 | Potassium channel (Ca-activated) activator | 0.171 0.021 DBMET02108 0.08 0.075 DB11091 0.171 0.021 DB09460 | DB09460 | |
| 0.024 | 0.173 | 0.06 | Matrix metalloproteinase inhibitor | 0.06 0.054 DBMET02108 0.06 0.054 DB09460 | DB09460 | |
| 0.026 | 0.176 | 0.084 | Acetylcholine M4 receptor antagonist | 0.084 0.042 DBMET02108 0.084 0.042 DB09460 | DB09460 | |
| 0.078 | 0.229 | 0.13 | Thiol protease inhibitor | 0.13 0.097 DBMET02108 0.127 0.102 DB11091 0.13 0.097 DB09460 | DB09460 | |
| 0.078 | 0.231 | 0.125 | Cyclin-dependent kinase 8 inhibitor | 0.125 0.11 DBMET02108 0.121 0.117 DB11091 0.125 0.11 DB09460 | DB09460 | |
| 0.011 | 0.166 | 0.044 | Purinergic P2Y antagonist | 0.044 0.032 DBMET02108 0.044 0.032 DB09460 | DB09460 | |
| 0.021 | 0.176 | 0.095 | Dopamine uptake inhibitor | 0.095 0.02 DBMET02108 0.095 0.02 DB09460 | DB09460 | |
| 0.079 | 0.235 | 0.217 | DNA methyltransferase I inhibitor | 0.217 0.061 DBMET02108 0.144 0.11 DB11091 0.217 0.061 DB09460 | DB09460 | |
| 0.129 | 0.287 | 0.305 | Antithrombotic | 0.305 0.085 DBMET02108 0.223 0.151 DB11091 0.305 0.085 DB09460 | DB09460 | |
| 0.032 | 0.191 | 0.071 | Metalloproteinase-2 inhibitor | 0.071 0.064 DBMET02108 0.071 0.064 DB09460 | DB09460 | |
| 0.07 | 0.23 | 0.143 | Pyruvate kinase inhibitor | 0.138 0.126 DBMET02108 0.143 0.122 DB11091 0.138 0.126 DB09460 | DB11091 | |
| 0.058 | 0.221 | 0.132 | Cytidine deaminase inhibitor | 0.132 0.089 DBMET02108 0.131 0.09 DB11091 0.132 0.089 DB09460 | DB09460 | |
| 0.083 | 0.249 | 0.161 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.161 0.13 DBMET02108 0.16 0.131 DB11091 0.161 0.13 DB09460 | DB09460 | |
| 0.076 | 0.244 | 0.126 | Neuropeptide Y1 antagonist | 0.126 0.108 DBMET02108 0.125 0.112 DB11091 0.126 0.108 DB09460 | DB09460 | |
| 0.039 | 0.208 | 0.067 | Orexin receptor 1 antagonist | 0.067 0.066 DBMET02108 0.067 0.066 DB09460 | DB09460 | |
| 0.037 | 0.206 | 0.089 | Inducible nitric-oxide synthase inhibitor | 0.089 0.049 DBMET02108 0.075 0.072 DB11091 0.089 0.049 DB09460 | DB09460 | |
| 0.022 | 0.191 | 0.068 | Neuronal nicotinic receptor antagonist | 0.068 0.047 DBMET02108 0.068 0.047 DB09460 | DB09460 | |
| 0.065 | 0.234 | 0.161 | Aryl hydrocarbon receptor agonist | 0.161 0.127 DBMET02108 0.151 0.134 DB11091 0.161 0.127 DB09460 | DB09460 | |
| 0.029 | 0.201 | 0.078 | Epoxide hydrolase inhibitor | 0.078 0.044 DBMET02108 0.078 0.044 DB09460 | DB09460 | |
| 0.069 | 0.241 | 0.146 | Phospholipase A2 inhibitor | 0.146 0.078 DBMET02108 0.146 0.078 DB09460 | DB09460 | |
| 0.015 | 0.188 | 0.062 | Acetylcholine M3 receptor antagonist | 0.062 0.039 DBMET02108 0.062 0.039 DB09460 | DB09460 | |
| 0.056 | 0.236 | 0.149 | Psychostimulant | 0.149 0.117 DBMET02108 0.149 0.117 DB11091 0.149 0.117 DB09460 | DB09460 | |
| 0.027 | 0.21 | 0.078 | Androgen antagonist | 0.078 0.068 DBMET02108 0.078 0.068 DB09460 | DB09460 | |
| 0.022 | 0.206 | 0.063 | Lysine-specific demethylase 1A inhibitor | 0.063 0.024 DBMET02108 0.063 0.024 DB09460 | DB09460 | |
| 0.029 | 0.212 | 0.093 | Bcr-Abl kinase inhibitor | 0.093 0.049 DBMET02108 0.093 0.049 DB09460 | DB09460 | |
| 0.075 | 0.263 | 0.212 | DNA methylase inhibitor | 0.212 0.072 DBMET02108 0.143 0.123 DB11091 0.212 0.072 DB09460 | DB09460 | |
| 0.088 | 0.276 | 0.15 | Focal adhesion kinase 2 inhibitor | 0.15 0.131 DBMET02108 0.145 0.139 DB11091 0.15 0.131 DB09460 | DB09460 | |
| 0.025 | 0.215 | 0.113 | Acetylcholine nicotinic antagonist | 0.113 0.033 DBMET02108 0.113 0.033 DB09460 | DB09460 | |
| 0.046 | 0.236 | 0.138 | AMP-activated protein kinase stimulant | 0.138 0.036 DBMET02108 0.138 0.036 DB09460 | DB09460 | |
| 0.057 | 0.247 | 0.203 | NADPH oxidase inhibitor | 0.203 0.033 DBMET02108 0.203 0.033 DB09460 | DB09460 | |
| 0.041 | 0.233 | 0.094 | Nitric-oxide synthase inhibitor | 0.094 0.07 DBMET02108 0.086 0.085 DB11091 0.094 0.07 DB09460 | DB09460 | |
| 0.088 | 0.282 | 0.188 | Calpain inhibitor | 0.188 0.125 DBMET02108 0.178 0.137 DB11091 0.188 0.125 DB09460 | DB09460 | |
| 0.054 | 0.259 | 0.181 | Antibacterial (Helicobacter pylori) | 0.181 0.028 DBMET02108 0.181 0.028 DB09460 | DB09460 | |
| 0.03 | 0.244 | 0.077 | Adrenaline agonist | 0.077 0.062 DBMET02108 0.077 0.062 DB09460 | DB09460 | |
| 0.096 | 0.311 | 0.294 | 12-Lipoxygenase inhibitor | 0.294 0.083 DBMET02108 0.177 0.176 DB11091 0.294 0.083 DB09460 | DB09460 | |
| 0.056 | 0.276 | 0.149 | Acetylcholine M1 receptor antagonist | 0.149 0.075 DBMET02108 0.149 0.075 DB09460 | DB09460 | |
| 0.044 | 0.273 | 0.2 | Beta amyloid protein antagonist | 0.2 0.017 DBMET02108 0.097 0.094 DB11091 0.2 0.017 DB09460 | DB09460 | |
| 0.032 | 0.262 | 0.107 | Mediator release inhibitor | 0.107 0.061 DBMET02108 0.107 0.061 DB09460 | DB09460 | |
| 0.037 | 0.284 | 0.118 | Acetylcholine muscarinic antagonist | 0.118 0.069 DBMET02108 0.118 0.069 DB09460 | DB09460 | |
| 0.029 | 0.277 | 0.094 | Potassium channel activator | 0.094 0.055 DBMET02108 0.094 0.055 DB09460 | DB09460 | |
| 0.09 | 0.338 | 0.193 | Histone acetyltransferase inhibitor | 0.193 0.079 DBMET02108 0.153 0.134 DB11091 0.193 0.079 DB09460 | DB09460 | |
| 0.017 | 0.266 | 0.078 | Alpha adrenoreceptor agonist | 0.078 0.039 DBMET02108 0.078 0.039 DB09460 | DB09460 | |
| 0.087 | 0.336 | 0.312 | Transcription factor NF kappa B inhibitor | 0.312 0.088 DBMET02108 0.195 0.174 DB11091 0.312 0.088 DB09460 | DB09460 | |
| 0.091 | 0.344 | 0.251 | Transcription factor STAT3 inhibitor | 0.251 0.082 DBMET02108 0.185 0.157 DB11091 0.251 0.082 DB09460 | DB09460 | |
| 0.036 | 0.291 | 0.123 | GABA receptor agonist | 0.123 0.054 DBMET02108 0.123 0.054 DB09460 | DB09460 | |
| 0.067 | 0.331 | 0.249 | Non-steroidal antiinflammatory agent | 0.249 0.043 DBMET02108 0.249 0.043 DB09460 | DB09460 | |
| 0.024 | 0.306 | 0.079 | I kappa B kinase inhibitor | 0.079 0.062 DBMET02108 0.079 0.062 DB09460 | DB09460 | |
| 0.103 | 0.391 | 0.352 | Antibacterial | 0.352 0.101 DBMET02108 0.284 0.148 DB11091 0.352 0.101 DB09460 | DB09460 | |
| 0.016 | 0.307 | 0.083 | NMDA receptor antagonist | 0.083 0.062 DBMET02108 0.083 0.062 DB09460 | DB09460 | |
| 0.065 | 0.357 | 0.192 | Tumour necrosis factor antagonist | 0.192 0.058 DBMET02108 0.192 0.058 DB09460 | DB09460 | |
| 0.035 | 0.327 | 0.119 | Acetylcholine antagonist | 0.119 0.071 DBMET02108 0.119 0.071 DB09460 | DB09460 | |
| 0.036 | 0.328 | 0.122 | Cholinergic antagonist | 0.122 0.072 DBMET02108 0.122 0.072 DB09460 | DB09460 | |
| 0.074 | 0.367 | 0.21 | Calpain 2 inhibitor | 0.21 0.179 DBMET02108 0.21 0.179 DB09460 | DB09460 | |
| 0.058 | 0.369 | 0.201 | Hemostatic | 0.201 0.032 DBMET02108 0.201 0.032 DB09460 | DB09460 | |
| 0.04 | 0.359 | 0.157 | Diuretic | 0.157 0.072 DBMET02108 0.157 0.072 DB09460 | DB09460 | |
| 0.044 | 0.382 | 0.254 | Spasmolytic | 0.254 0.089 DBMET02108 0.254 0.089 DB09460 | DB09460 | |
| 0.047 | 0.388 | 0.296 | Nitric oxide antagonist | 0.296 0.041 DB11091 | DB11091 | |
| 0.035 | 0.379 | 0.109 | Toll-Like receptor antagonist | 0.109 0.104 DBMET02108 0.109 0.104 DB09460 | DB09460 | |
| 0.07 | 0.415 | 0.24 | Transcription factor STAT inhibitor | 0.24 0.094 DBMET02108 0.24 0.094 DB09460 | DB09460 | |
| 0.063 | 0.448 | 0.183 | Hypoxia-inducible factor 1 alpha inhibitor | 0.183 0.175 DBMET02108 0.183 0.175 DB09460 | DB09460 | |
| 0.046 | 0.439 | 0.16 | Antipruritic | 0.16 0.083 DBMET02108 0.16 0.083 DB09460 | DB09460 | |
| 0.005 | 0.458 | 0.117 | Phosphodiesterase 2A inhibitor | 0.117 0.007 DB11091 | DB11091 | |
| 0.005 | 0.484 | 0.125 | Phosphodiesterase II inhibitor | 0.125 0.007 DB11091 | DB11091 | |
| 0.027 | 0.549 | 0.209 | Antiamyloidogenic | 0.209 0.094 DBMET02108 0.209 0.094 DB09460 | DB09460 | |
| 0.007 | 0.698 | 0.095 | H+/K+-transporting ATPase inhibitor | 0.095 0.009 DB11091 | DB11091 | |
| 0.005 | 0.858 | 0.335 | Mcl-1 antagonist | 0.335 0.017 DB11091 | DB11091 | |
| 0.004 | 0.862 | 0.085 | Bcl2 antagonist | 0.085 0.028 DB11091 | DB11091 | |
| 0.004 | 0.863 | 0.191 | 5-Lipoxygenase inhibitor | 0.191 0.026 DB11091 | DB11091 | |
| 0.003 | 0.932 | 0.157 | Phosphodiesterase 4D inhibitor | 0.157 0.018 DB11091 | DB11091 | |
| 0 | 0.949 | 0.036 | Immunosuppressant Cyclosporine-like | 0.036 0.001 DBMET02108 0.036 0.001 DB09460 | DB09460 | |
| 0.008 | 0.995 | 0.127 | Lipocortins synthesis agonist | 0.127 0.003 DBMET02108 0.127 0.003 DB09460 | DB09460 | |
| 0.001 | 0.992 | 0.047 | Corticosteroid-like | 0.047 0.003 DBMET02108 0.047 0.003 DB09460 | DB09460 | |
| 0.003 | 0.996 | 0.379 | Platelet antagonist | 0.379 0.032 DBMET02108 0.379 0.032 DB09460 | DB09460 | |
| 0.001 | 0.996 | 0.088 | Retinoic acid alpha receptor agonist | 0.088 0.004 DBMET02108 0.088 0.004 DB09460 | DB09460 | |
| 0.003 | 0.999 | 0.837 | NOS3 expression enhancer | 0.837 0.002 DBMET02108 0.837 0.002 DB09460 | DB09460 | |
| 0.001 | 0.998 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 DBMET02108 0.053 0.037 DB09460 | DB09460 | |
| 0 | 0.997 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 DBMET02108 0.014 0.01 DB09460 | DB09460 | |
| 0.001 | 0.998 | 0.044 | Catechol O-methyltransferase inhibitor | 0.044 0.011 DBMET02108 0.044 0.011 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.186 | Toll-Like receptor 4 antagonist | 0.186 0.008 DBMET02108 0.186 0.008 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.999 | Analgesic | 0.999 0.001 DBMET02108 0.999 0.001 DB09460 | DB09460 | |
| 0 | 0.998 | 0.157 | Microtubule stabilization | 0.157 0.002 DBMET02108 0.157 0.002 DB09460 | DB09460 | |
| 0 | 0.998 | 0.061 | Squalene synthetase inhibitor | 0.061 0.011 DBMET02108 0.061 0.011 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.477 | Potassium channel large-conductance Ca-activated activator | 0.477 0.004 DBMET02108 0.477 0.004 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.448 | Chelator | 0.448 0.005 DBMET02108 0.448 0.005 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.095 | Glucose-6-phosphate translocase inhibitor | 0.095 0.007 DBMET02108 0.095 0.007 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.698 | Vanilloid agonist | 0.698 0.002 DBMET02108 0.698 0.002 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.345 | Catenin beta inhibitor | 0.345 0.004 DBMET02108 0.345 0.004 DB09460 | DB09460 | |
| 0 | 0.998 | 0.003 | Antibiotic Penicillin-like | 0.003 0.002 DBMET02108 0.003 0.002 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.11 | HIV-1 integrase inhibitor | 0.11 0.02 DBMET02108 0.11 0.02 DB09460 | DB09460 | |
| 0 | 0.999 | 0.344 | Leukotriene synthesis inhibitor | 0.344 0.004 DBMET02108 0.344 0.004 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.262 | Antioxidant | 0.262 0.077 DBMET02108 0.262 0.077 DB09460 | DB09460 | |
| 0.001 | 0.999 | 0.198 | Bone formation stimulant | 0.198 0.036 DBMET02108 0.198 0.036 DB09460 | DB09460 | |
| 0 | 0.999 | 0.13 | Aminoacyl-tRNA synthetase inhibitor | 0.13 0.025 DBMET02108 0.13 0.025 DB09460 | DB09460 | |
| 0 | 0.999 | 0.018 | Purinergic P2T antagonist | 0.018 0.017 DBMET02108 0.018 0.017 DB09460 | DB09460 | |
| 0 | 0.999 | 0.244 | Topoisomerase II alpha inhibitor | 0.244 0.01 DBMET02108 0.244 0.01 DB09460 | DB09460 | |
| 0 | 0.999 | 0.019 | Glucocorticoid agonist | 0.019 0.008 DBMET02108 0.019 0.008 DB09460 | DB09460 | |
| 0 | 0.999 | 0.119 | Thrombolytic | 0.119 0.112 DBMET02108 0.119 0.112 DB09460 | DB09460 | |
| 0 | 0.999 | 0.57 | Topoisomerase I inhibitor | 0.57 0.003 DBMET02108 0.57 0.003 DB09460 | DB09460 | |
| 0 | 0.999 | 0.125 | Beta tubulin antagonist | 0.125 0.016 DBMET02108 0.125 0.016 DB09460 | DB09460 | |
| 0 | 0.999 | 0.228 | Topoisomerase II inhibitor | 0.228 0.028 DBMET02108 0.228 0.028 DB09460 | DB09460 | |
| 0 | 0.999 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.019 DBMET02108 0.035 0.019 DB09460 | DB09460 | |
| 0 | 0.999 | 0.241 | Thioredoxin inhibitor | 0.241 0.005 DBMET02108 0.241 0.005 DB09460 | DB09460 | |
| 0 | 0.999 | 0.341 | Gonadotropin-releasing hormone receptor agonist | 0.341 0.003 DBMET02108 0.341 0.003 DB09460 | DB09460 | |
| 0 | 0.999 | 0.539 | Hypoglycemic | 0.539 0.012 DBMET02108 0.539 0.012 DB09460 | DB09460 | |
| 0 | 0.999 | 0.15 | CC chemokine receptor 2B antagonist | 0.15 0.004 DBMET02108 0.15 0.004 DB09460 | DB09460 | |
| 0 | 0.999 | 0.48 | P-glycoprotein inhibitor | 0.48 0.009 DBMET02108 0.48 0.009 DB09460 | DB09460 | |
| 0 | 1 | 0.543 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.543 0.004 DBMET02108 0.543 0.004 DB09460 | DB09460 | |
| 0 | 0.999 | 0.16 | Breast cancer-resistant protein inhibitor | 0.16 0.021 DBMET02108 0.16 0.021 DB09460 | DB09460 | |
| 0 | 0.999 | 0.214 | Antiviral (Hepatitis D) | 0.214 0.003 DBMET02108 0.214 0.003 DB09460 | DB09460 | |
| 0 | 0.999 | 0.565 | Platelet adhesion inhibitor | 0.565 0.004 DBMET02108 0.565 0.004 DB09460 | DB09460 | |
| 0 | 0.999 | 0.057 | Plasmin inhibitor | 0.057 0.029 DBMET02108 0.057 0.029 DB09460 | DB09460 | |
| 0 | 0.999 | 0.176 | Nitric oxide donor | 0.176 0.002 DBMET02108 0.176 0.002 DB09460 | DB09460 | |
| 0 | 0.999 | 0.165 | Transcription factor AP-1 inhibitor | 0.165 0.005 DBMET02108 0.165 0.005 DB09460 | DB09460 | |
| 0 | 1 | 0.537 | Vasodilator | 0.537 0.009 DBMET02108 0.537 0.009 DB09460 | DB09460 | |
| 0 | 0.999 | 0.038 | Factor XIa inhibitor | 0.038 0.032 DBMET02108 0.038 0.032 DB09460 | DB09460 | |
| 0 | 1 | 0.385 | DNA intercalator | 0.385 0.008 DBMET02108 0.385 0.008 DB09460 | DB09460 | |
| 0 | 1 | 0.429 | Tumour necrosis factor alpha release inhibitor | 0.429 0.022 DBMET02108 0.429 0.022 DB09460 | DB09460 | |
| 0 | 1 | 0.204 | Cyclin-dependent kinase 7 inhibitor | 0.204 0.032 DBMET02108 0.204 0.032 DB09460 | DB09460 | |
| 0 | 1 | 0.63 | Antimitotic | 0.63 0.006 DBMET02108 0.63 0.006 DB09460 | DB09460 | |
| 0 | 1 | 0.999 | Glycogen synthase kinase-3 inhibitor | 0.999 0 DBMET02108 0.999 0 DB09460 | DB09460 | |
| 0 | 1 | 0.075 | Viral attachment inhibitor | 0.075 0.061 DBMET02108 0.075 0.061 DB09460 | DB09460 | |
| 0 | 1 | 0.999 | Adrenaline uptake inhibitor | 0.999 0 DBMET02108 0.999 0 DB09460 | DB09460 | |
| 0 | 1 | 0.999 | Nootropic | 0.999 0 DBMET02108 0.999 0 DB09460 | DB09460 | |
| 0 | 1 | 0.101 | Elastase inhibitor | 0.101 0.01 DBMET02108 0.101 0.01 DB09460 | DB09460 | |
| 0 | 1 | 0.028 | Histamine H3 receptor agonist | 0.028 0.019 DBMET02108 0.028 0.019 DB09460 | DB09460 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |